Biotechnology News

Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.

Curemeta LLC to Present at IBC Life Science 2015

Curemeta LLC to Present at IBC Life Science 2015

Curemeta LLC, a Boston-based oncology biotech, will be at the IBC Life Science Conference in San Francisco. They will be presenting data on their ADCs which target pluripotent cancer stem cells. - May 16, 2015 - Curemeta LLC

Bipolar Missouri Artist Albert P. Carpenter Chosen to Show Polyhedral Art at 2015 Bridges Conference in Baltimore, Maryland

Albert P. Carpenter, Bipolar artist and author of several blogs, will be showing his polyhedral art at the 2015 Bridges Conference in Baltimore, MD. He hopes to meet scientists who may someday use 3D chemical printing to convert his polyhedral models into molecules for use in medicine and industry. - May 14, 2015 - Berts Quest

IQ4I Research & Consultancy Published a New Report on “Biochips (Microarrays/Lab-on-Chip) Global Market”

The global Biochips market is expected to reach $13.1 billion by 2021. This report analyzes the biochips market in terms of market revenue ($ million) for all segments. - May 13, 2015 - IQ4I Research & Consultancy Pvt. Ltd.

IQ4I Research & Consultancy Published a New Report on “Chronic Kidney Disease (CKD) Pipeline Analysis"

CKD provides a tremendous opportunity for upcoming therapies specific to CKD such asMAbs, stem cell-based and RNA-based therapies, which reverses disease course or slow down kidney deterioration. - May 11, 2015 - IQ4I Research & Consultancy Pvt. Ltd.

Affinity Biologicals Inc. Introduces Laboratories to the New Factor VII Kit to Their Line of Factor VIII Inhibitor Kits

Affinity Biologicals Inc. is excited to announce that in order improve quantitative thrombosis and hemostasis research they are introducing laboratories to the Factor VII Antigen Elisa Kit, a new addition to the existing Factor VIII Inhibitor Kits. - May 08, 2015 - Affinity Biologicals

Save Time Job Posting - Use Job Scraping

Save Time Job Posting - Use Job Scraping

Job scraping tool can save pharma recruiters and employers huge amounts of time. - May 07, 2015 - PharmiWeb.com

Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at Its Crystal Ball Gala

Annual event raises $110,000 for research and outreach to eliminate hepatitis B that affects more than 12 million Americans and 2 billion people worldwide. - May 07, 2015 - Hepatitis B Foundation

Baruch S. Blumberg Institute Partners with University of Pennsylvania for Master of Chemical Sciences Program

Partnership will offer work experience for Penn graduate students, research support for Institute - May 03, 2015 - Hepatitis B Foundation

Creative Biomart Launches an Intuitive New Website Design to Enhance User Experience

Creative Biomart Launches an Intuitive New Website Design to Enhance User Experience

Creative Biomart, the leading company in the supply of diagnostic antigens and antibodies, pharmaceutical enzymes, diagnostic enzymes, and high-quality recombinant proteins has launched an intuitive new website design as well as coupon promotion. - April 29, 2015 - Creative Biomart

Paras Biopharmaceuticals Finland Oy Selected as First Finnish Company to Present at Cavendish Global

Paras Biopharmaceuticals Finland Oy, an upcoming biopharmaceutical manufacturing company for biosimilars and therapeutic peptides, announced today that it has been selected to present at the Cavendish Global Health Impact Forum taking place 10th - 14th May in La Jolla, California, USA. The purpose... - April 28, 2015 - Paras Biopharmaceuticals Finland Oy

Affinity Biologicals Inc. Explains the Difference between Polyclonal vs Monoclonal Antibodies

As a provincially licensed research facility, a large portion of Affinity Biological Inc.’s work involves purifying proteins and developing assays. Currently, they manufacture 2 types of antibodies for research applications: polyclonals and monoclonals. - April 22, 2015 - Affinity Biologicals

Ministry of Food and Drug Safety (MFDS) Clearance for GenASIs HiPath IHC Family

Applied Spectral Imaging received South Korean Ministry of Food and Drug Safety (MFDS) Clearance for GenASIs™ HiPath IHC Family for HER2, ER, PR and Ki67 - April 18, 2015 - Applied Spectral Imaging

Karcinolys Announces the Formation of Pancrealys, Its New Pancreatic Cancer Division

Pancreatic cancer selected as first indication for Targeted HSV-1 derived oncolytic virus Myb34.5. - April 17, 2015 - Karcinolys

MR Solutions Brings Preclinical MRI Technology to Class 3 and 4 Laboratories

Preclinical cryogen-free MRI multi-modality benchtop scanners are now available for Class 3 and 4 laboratories. - April 15, 2015 - MR Solutions

Eagle Biosciences Announces the Launch of Multispecies 25-OH Vitamin D ELISA Assay Kit

Eagle Biosciences Announces the Launch of Multispecies 25-OH Vitamin D ELISA Assay Kit

Eagle Biosciences, Inc. introduces a simple ELISA to measure both 25-OH Vitamin D2 and D3 equally in multiple species such as bovine, goat, horse, chicken, mouse, rat, rabbit and equine. - April 14, 2015 - Eagle Biosciences, Inc.

The State of California Invests in VIRUN® NutraBIOsciences™; VIRUN® Receives Two More Patent Grants in China While Premiering Esolv® Vitamin E Encapsulator

The State of California Invests in VIRUN® NutraBIOsciences™; VIRUN® Receives Two More Patent Grants in China While Premiering Esolv® Vitamin E Encapsulator

The State of California has invested in VIRUN, Inc., this along with two newly granted patents in China that correlate with the release of VIRUN’s Esolv®. Algatech to premiere their AstaPure® branded Astaxanthin in a new clear, water soluble powder utilizing VIRUN’s Esolv®, clean label claim encapsulator, for beverage and liquid applications. - April 07, 2015 - VIRUN

Voicebrook to Exhibit at APF Pathology Coding & Practice Management Seminar

Voicebrook to Exhibit at APF Pathology Coding & Practice Management Seminar

Voicebrook to demonstrate accurate reporting tools that support billing for services. - April 07, 2015 - Voicebrook, Inc.

CytoTest and Uniformed Services University’s Center for Prostate Disease Research Enter Into CRADA to Advance Cancer Diagnosis and Prognosis

CytoTest and Uniformed Services University’s Center for Prostate Disease Research Enter Into CRADA to Advance Cancer Diagnosis and Prognosis

CytoTest Inc., the Uniformed Services University of the Health Sciences (USU), and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) announced today that they have signed a Cooperative Research and Development Agreement (CRADA). Under the terms of the CRADA,... - March 31, 2015 - CytoTest Inc.

Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists

"All-star" researchers intend to develop breakthrough therapies for the viral liver infection within 3 years. - March 28, 2015 - Hepatitis B Foundation

Prosidyan™ Announces FDA 510(k) Clearance of FIBERGRAFT™BG Putty – Bone Graft Substitute

NJ-based Prosidyan™ (www.prosidyan.com), developer of proprietary fiber-based bioactive glass products, announced today that it has received FDA 510(k) clearance of FIBERGRAFT™ BG Putty – Bone Graft Substitute. This is the second generation product in the company’s... - March 26, 2015 - Prosidyan, Inc.

Celprogen Released Stem Cell Active Ingredients for the Cosmetic Industry Tested and Validated in Cosmetic Products for a Decade

Celprogen Released Stem Cell Active Ingredients for the Cosmetic Industry Tested and Validated in Cosmetic Products for a Decade

Celprogen Inc., a leader in the Stem Cell Research and Therapeutics industry for the development of stem cell technologies for regenerative medicine, today announced that they have adult stem cell derived conditioned media containing stem cells growth components for the skin care regenerative... - March 25, 2015 - Celprogen Inc

Navigen Announces Phase II NIH SBIR Award for the Advancement of Ebola Virus Therapy

Navigen, Inc., a Utah-based drug discovery and development company, has received an NIH award for $2.9 million to develop its anti-Ebola virus D-peptide. Navigen's compound targets a region of the Ebola virus that is 100% conserved and thus should be effective against all strains of virus. - March 24, 2015 - Navigen, Inc.

AveXis EU Ltd. Granted SME Status by the European Medicines Agency

AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), today announced that the European Medicines Agency (EMA) has granted AveXis’ wholly owned European subsidiary,... - March 21, 2015 - AveXis Inc.

Recursion Pharmaceuticals Announces Funding Support for Ataxia-Telangiectasia

Recursion today announced a grant from the AT-Children's Project to advance it's innovative drug discovery work towards identifying novel treatments for ataxia-telangiectasia, a brutal childhood genetic disease. - March 20, 2015 - Recursion Pharmaceuticals

Global Dental 3D Printing Market to Reach $752.5 Million by the Year 2020

The dental 3D printing market is mainly driven by the growing acceptance of 3D printing among the dental laboratories, widening applications of 3D printing in dentistry, government initiatives to promote research activities in 3D printing, increased investments by key players to incorporate the 3D printing technology, and the continuous technological advancements in this field. - March 18, 2015 - Meticulous Research

Grow Your Mind with VoiceOver Solution at The United States and Canadian Academy of Pathology Annual Meeting

Grow Your Mind with VoiceOver Solution at The United States and Canadian Academy of Pathology Annual Meeting

Voicebrook to demonstrate Pathology Reporting Solution at prestigious conference. - March 17, 2015 - Voicebrook, Inc.

Creative Bioarray Introduces Hek 293 Cells for Specific Research Needs

The US-based biotech company, Creative Bioarray has recently Introduced Hek 293 cells into its cell repository for meeting customers’ specific research needs. - March 16, 2015 - Creative Bioarray

China Patent for Therapeutic Vaccine Treatment of Obesity to be Granted to Braasch Biotech

China Patent for Therapeutic Vaccine Treatment of Obesity to be Granted to Braasch Biotech

China's State Intellectual Property Office to grant Braasch Biotech's patent on Therapeutic treatment of human and pet obesity. - March 13, 2015 - Braasch Biotech LLC

Houston Biotech Firm Closes $7.3 Million Fundraising Round

Early-stage life science commercialization company Fannin Partners, LLC announced the completion of its private offering of Class A units. Proceeds from the offering will fund the further expansion of the company’s portfolio of startups. - March 06, 2015 - Fannin Partners, LLC

AveXis Announces the Formation of Its European Subsidiary, AveXis EU, Ltd.

AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), today announced the formation of its EU-based wholly-owned subsidiary, AveXis EU, Ltd. The subsidiary will allow AveXis... - February 27, 2015 - AveXis Inc.

Strathmore’s Who’s Who Honors Robert Schiestl with Special Times Square Appearance

Strathmore’s Who’s Who Honors Robert Schiestl with Special Times Square Appearance

Robert Schiestl, of Encino, California has recently been recognized by Strathmore’s Who’s Who for his outstanding contributions and achievements in the field of Higher Education-Pathology and Cancer Research. In honor of his accomplishments and professionalism, Dr. Schiestl‘s image was projected over Times Square, New York, on February 6th, 2015. - February 19, 2015 - Strathmore Who's Who

Affinity Biologicals Inc. Releases New Feature with Polyclonal Coagulation Antibodies Over Monoclonal Coagulation Antibodies for Quantitative Research

For over 28 years, Affinity Biologicals Inc. has been producing a diverse number of products for research and diagnostic purposes. - February 17, 2015 - Affinity Biologicals

Scientists Change the World - Now They Can Get Published and Rewarded at the Same Time

The “My Science Matters” initiative at Pipette.com will tell the stories of scientists and how their research helps others. Researchers and organizations can easily submit an overview of their work for publication and as an incentive February submission receive shopping credit towards any purchase at Pipette.com. - February 15, 2015 - Pipette.com

AnaSpec Launches Industry’s First Assay for Measuring Matriptase Activity

AnaSpec is pleased to announce the launch of the first commercially available kit for measuring the activity of Matriptase, a protease implicated in carcinogenesis. The SensoLyte® Rh110 Matriptase Assay Kit provides a convenient assay for screening of Matriptase inhibitors and activators or... - February 13, 2015 - AnaSpec, EGT Group

Small Animal Imaging (In-Vivo) Market is Expected to Reach $2.1 Billion, Globally, by 2020 - Allied Market Research

Global Small Animal Imaging (In-Vivo) Market (Technology, Application and Geography) - Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013-2020 - February 07, 2015 - Allied Market Research

IQ4I Research & Consultancy Published a New Report on “Contract Drug Discovery Research Outsourcing (CDDRO) Global Market”: Estimated to be Worth $22.7 Billion by 2018

IQ4I Research & Consultancy published a new report on “Contract Drug Discovery Research Outsourcing (CDDRO) Global Market – Forecast To 2018 analyzes and studies the major competition, market drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific and Rest of the World, spread through 168 slide. - February 04, 2015 - IQ4I Research & Consultancy Pvt. Ltd.

Hepatitis B Foundation Welcomes Two New Board Members

Pharmaceutical industry executive Wayne Yetter and engineering industry executive Craig Esterly to serve on board of national nonprofit research and disease advocacy organization - January 29, 2015 - Hepatitis B Foundation

Implantable Artificial Kidney Corporation Seals Deal for 500K Funding

Implantable Artificial Kidney Corporation Seals Deal for 500K Funding

Funding will be used for further research and development of their IAK-1 artificial kidney prototype. - January 28, 2015 - Implantable Artificial Kidney Corporation

Creative Bioarray Releases New Stem Cell Products

The US-based biotech company, Creative Bioarray has recently added hundred of kinds of stem cell products to its cell product repository. - January 24, 2015 - Creative Bioarray

Dr. John Wiktorowicz Brings in Rich Experience in Protein Biochemistry as PREMIER Biosoft Expands Its Mass Spectrometry Portfolio

PREMIER Biosoft today announced that eminent protein biochemist, John Wiktorowicz, PhD, has joined the company’s scientific advisory board. “We are very pleased to welcome Dr. Wiktorowicz to our scientific advisory board and look forward to his guidance as we deploy informatics to... - January 23, 2015 - PREMIER Biosoft International

Boston Healthcare Appoints Andreas H. Sander as Vice President and Managing Director of Boston Healthcare International GmbH

Boston Healthcare today announced the appointment of Andreas Sander as Vice President and Managing Director for Boston Healthcare International GmbH, leading the European team and the firm’s activities in Germany and Europe out of Boston Healthcare’s Berlin office. Mr. Sander brings... - January 21, 2015 - Boston Healthcare

VIRUN® NutraBIOsciences™ to Present at BEVERAGE INNOVATION 2015 on February 4th – Hear VIRUN talk Innovation from Water to Beer

VIRUN® NutraBIOsciences™ to Present at BEVERAGE INNOVATION 2015 on February 4th – Hear VIRUN talk Innovation from Water to Beer

VIRUN to present the latest-and-greatest at Beverage Innovation 2015, presented to you by FoodNavigator-USA and BeverageDaily. From cognitive waters containing Phosphatidylserine, DHA Omega-3 and weight-loss waters with high levels of Resveratrol and Curcumin that help regulate blood sugar, to heart-healthy waters containing 1000mg Phytosterols and 680mg EPA DHA Omega-3. From water to beer, raw material to finished product, VIRUN is your solutions-based resource. - January 20, 2015 - VIRUN

The 2013-2018 Outlook for Bioterrorism Detection Equipment in India

MarketreportsonIndia.com presents the report on "The 2013-2018 Outlook for Bioterrorism Detection Equipment in India." This report covers the latent demand outlook for bioterrorism detection equipment across the states, union territories and cities of India. - January 20, 2015 - Market Reports on India

Affinity Life Sciences to Produce Lyophilized Chem-Bio Assays for SRC Acumen

Affinity Life Sciences to Produce Lyophilized Chem-Bio Assays for SRC Acumen

SRC Acumen announced the continued and exclusive production of lyophilized qPCR and toxin assays by Affinity Life Sciences. - January 16, 2015 - Affinity Life Sciences

CHI Scientific Releases PrimaCell™ Protocols for Culturing More Than 300 Types of Primary Cells to Speed Biological Discoveries

Brings Standardized Methods to the Research Scientist, Greatly Reducing the Time Needed to Prepare and Culture Critical Tissue and Organ Cells. - January 16, 2015 - CHI Scientific Inc

Braasch Biotech Bolsters Intellectual Property with Patent Acceptance in the Philippines

Braasch Biotech LLC continues patent portfolio expansion with new issue in the Philippines. Novel technologies allow safe enhancement of livestock productivity by use of vaccination rather than exogenous pharmaceuticals. - January 15, 2015 - Braasch Biotech LLC

AveXis Closes Its Series C Financing Round with Deerfield Management and Roche Venture Fund

AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), today announced it has completed a $10 million financing round led by Deerfield Management and Roche Venture Fund. In... - January 08, 2015 - AveXis Inc.

Good News - Creative Biomart Newly Introduced Fucose-Free Protein Expression System

Creative Biomart, a world leading biotech company that specializes in providing advanced tolls for protein expression and purification, today has officially announced its release of novel service--Fucose-free Protein Expression System. According to its official speaker, this service is supported by... - January 07, 2015 - Creative Biomart

Verix Highlights 12 of the Most Important Trends and Events That Influenced the Pharma Industry in 2014

Verix Highlights 12 of the Most Important Trends and Events That Influenced the Pharma Industry in 2014

2014 has witnessed innovative disruption in healthcare and life sciences industries. This, therefore, calls for celebration in honor of the value and contributions that healthcare companies and organizations have offered us this year. To recognize of these milestones that have impacted us in 2014, Verix has decided to share these 12 important events that played a role in Pharma industry in a number of ways. - December 29, 2014 - Verix

Creative Biomart Launches Special Promotion for Christmas and New Year

Creative Biomart, a world leading biotech company that provides recombinant proteins, enzymes and other quality products and services for customers all over the world, has announced today that they would launch a special promotion for Christmas and New year in this very day. According to its... - December 25, 2014 - Creative Biomart

Press Releases 951 - 1,000 of 2,208